JHJiachun Huang

Jiachun Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiachun Huang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Formononetin Protects Osteoblasts Against Oxidative Stress and Attenuates Ovariectomy-Induced Bone Loss in Association with MAPK/AP-1 and NRF2 Signaling

    by Shuhua Liu, Ruolin Wang, Chenhaoyu Liu, Jiachun Huang, Xiaoyun Li, Haomin Qian, Hongxing Huang, Lei Wan

    Postmenopausal osteoporosis (PMOP) is associated with estrogen deficiency and oxidative stress (OS), which impair osteoblast survival and osteogenic function. Formononetin (FMN) is a phytoestrogen with antioxidant properties, but its protective effects on osteoblasts under OS and the signaling pathways associated with these effects remain incompletely understood. Here, we evaluated the effects of FMN in ovariectomized (OVX) mice and in a tert-butyl hydroperoxide (t-BOOH)-induced oxidative injury model in MC3T3-E1 cells. Bone microarchitecture, histology, serum OS markers, cell viability, reactive oxygen species (ROS) production, apoptosis, mitochondrial morphology, and osteogenic differentiation were assessed. Network pharmacology, molecular docking, molecular dynamics simulations, RNA sequencing, Western blotting, and pharmacological pathway-modulation experiments were used to investigate signaling changes associated with FMN treatment. FMN attenuated trabecular bone deterioration and systemic oxidative imbalance in OVX mice. In MC3T3-E1 cells, FMN improved cell viability, reduced ROS accumulation and apoptosis, alleviated mitochondrial damage, and preserved osteogenic differentiation following t-BOOH exposure. FMN treatment was accompanied by reduced phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), p38, and c-Jun N-terminal kinase (JNK), together with reduced expression of activator protein 1 (AP-1)-related proteins, including c-Fos, c-Jun, and phosphorylated c-Jun. Pharmacological reactivation of p38/JNK signaling with anisomycin attenuated several antioxidant, anti-apoptotic, and pro-osteogenic effects associated with FMN treatment, whereas nuclear factor erythroid 2-related factor 2 (NRF2) inhibition partially diminished FMN-mediated protection. Collectively, these findings support an association between the protective effects of FMN and modulation of mitogen-activated protein kinase (MAPK)/AP-1 and NRF2-associated signaling.

  • Open Access

    The Diagnostic Value of Image-Based Machine Learning for Osteoporosis: Systematic Review and Meta-Analysis

    by Rui Zhao, Haolin Yang, Yangbo Li, Xiaoyun Li, Zhijie Yang, Yanping Lin, Jiachun Huang, Lei Wan, Hongxing Huang

    Background: Osteoporosis (OP) is projected to be a major issue significantly impacting the well-being of middle-aged and old populations. Machine learning (ML) and deep learning (DL) models developed based on medical imaging have enhanced clinicians’ diagnostic accuracy and work efficiency. However, the diagnostic performance of different types of medical imaging for OP has not been systematically assessed. Objective: By summarizing related literature, this study aims to elucidate the role of DL models based on different medical imaging modalities in OP detection. Methods: PubMed, Embase, the Cochrane Library, and Web of Science were systematically searched for studies using ML for the diagnosis of OP based on medical imaging. The final search was conducted on May 16, 2024. The risk of bias in the included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. A bivariate mixed-effects model was applied to perform meta-analyses of sensitivity (SEN) and specificity (SPC), stratified by imaging modality (x-ray, computed tomography [CT], magnetic resonance imaging [MRI]). In addition, subgroup analyses were carried out based on the type of ML algorithm, the method of validation dataset generation, and the anatomical site of assessment. Results: A total of 60 studies comprising 66,195 participants were encompassed in this systematic review and meta-analysis. Among these, 22 studies used x-ray imaging, 37 applied CT imaging, and 3 used MRI for ML-based OP diagnosis. For x-ray–based models, the pooled SEN and SPC for studies focusing on the appendicular skeleton were 0.97 (95% CI 0.83‐0.99) and 0.90 (95% CI 0.75‐0.96), respectively. For studies using the mandible as the target site, SEN and SPC were 0.94 (95% CI 0.89‐0.97) and 0.80 (95% CI 0.56‐0.93), respectively. For those focusing on the lumbar spine, the pooled SEN and SPC were 0.87 (95% CI 0.77‐0.93) and 0.82 (95% CI 0.75‐0.87), respectively. For CT-based models, studies targeting the hip joint reported a pooled SEN and SPC of 0.87 (95% CI 0.83‐0.90) and 0.92 (95% CI 0.81‐0.96), respectively. For the thoracic spine, SEN and SPC were 0.91 (95% CI 0.86‐0.94) and 0.94 (95% CI 0.92‐0.95), respectively, while for the lumbar spine, they were 0.91 (95% CI 0.87‐0.94) and 0.92 (95% CI 0.86‐0.95), respectively. Conclusions: ML based on medical imaging demonstrates high diagnosis accuracy for OP, particularly DL models using x-ray and CT modalities. However, this study included only a limited number of original studies using MRI-based ML, and there remains a lack of adequate external validation across studies, which poses interpretative limitations. Future research should aim to develop artificial intelligence tools with broader applicability and enhanced diagnostic precision.


  • Open Access

    Expression profile analysis of long non-coding RNA in skeletal muscle of osteoporosis by microarray and bioinformatics

    by Shaojin Liu, Hongxing Huang, Shuang Chai, Hewei Wei, Jiachun Huang, Lei Wan

    Osteoporosis (OP) is a condition featured by bone mass loss and bone tissue microarchitectural alterations due to impaired tissue homeostasis favoring excessive bone resorption versus deposition. The trigger of such an impairment and the downstream molecular pathways involved are yet to be clarified. Long non-coding RNA (lncRNA) plays a role in gene transcription, protein expression and epigenetic regulation; and altered expression results in immune or metabolism related desease development. To determine whether lncRNAs are involved in osteoporosis, we analyzed the expression profile of lncRNAs and mRNAs in osteoporosis. Three pairs of osteoporosis patients (OP group) and healthy people controls (NC group) were screened by microarray. Quantitative polymerase chain reaction (qRT-PCR) was performed to confirm dysregulated lncRNA expressions in 5 pairs of OP and NC group tissues samples. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to construct the lncRNA-mRNA co-expression network. Through co-expression analysis, differently expressed transcripts were divided into modules, and lncRNAs were functionally annotated. We further analyzed the clinical significance of crucial lncRNAs from modules in public data. Finally, the expression of five lncRNAs, CUST_44695_PI430048170-GeneSymbol:CTA-384D8.35;CUST_39447_PI430048170,CUST_73298_PI430048170,CUST_108340_PI430048170,CUST_118927_PI430048170,this four lncRNAs have not been annotation genes and have not found GeneSymbols, and by quantitative RT-PCR, which may be associated with osteoporosis patients’ overall survival. Analysis of this study revealed that dysregulated lncRNAs and mRNAs in osteoporosis patients and health people controls could affect the immune or metabolism system and musculoskeletal cell differentiation. The biological functions of those lncRNAs need to be further validated.